Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

1.1K
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
1.1K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

120
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
120
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

79
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
79
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

904
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
904
Adhesion01:14

Adhesion

45.2K
Adhesion occurs when one type of molecule is attracted to a different molecule. Water exhibits adhesive properties in the presence of polar surfaces, such as glass or cellulose in plants. For instance, when water is poured into a glass, the positively charged hydrogen molecules of water are more attracted to the negatively charged oxygen molecules in the silica than to the oxygen in neighboring water molecules.
Capillary action is a result of water’s adhesive tendencies. When a narrow...
45.2K
Surface Active Agents01:27

Surface Active Agents

31
Surfactants, named for their behavior at interfaces, positively adsorb at the interfaces of two phases, reducing interfacial tension. Their versatility as emulsifiers, detergents, and foaming agents stems from this ability. Surfactants, often termed amphiphiles, share the property of amphipathy, with molecules having both hydrophilic and hydrophobic portions. The hydrophilic part is called the head, and the hydrophobic part, including an elongated alkyl substituent, forms the tail.Surfactants...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical case-viewing sessions in dermatology: the patient perspective.

Cutis·2020
Same author

Current treatment options for acanthosis nigricans.

Clinical, cosmetic and investigational dermatology·2018
Same author

Rosacea Comorbidities.

Dermatologic clinics·2018
Same author

Rosacea Triggers: Alcohol and Smoking.

Dermatologic clinics·2018
Same author

A Case Report Highlighting the Effective Treatment of Alopecia Universalis With Tofacitinib in an Adolescent and Adult Patient.

Journal of cutaneous medicine and surgery·2018
Same author

Insights into future therapeutics for atopic dermatitis.

Expert opinion on pharmacotherapy·2018

Related Experiment Video

Updated: Mar 7, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.7K

Increasing Adherence with Topical Agents for Atopic Dermatitis.

Nupur U Patel1, Veronica D'Ambra1, Steven R Feldman2,3,4

  • 1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

American Journal of Clinical Dermatology
|February 26, 2017
PubMed
Summary
This summary is machine-generated.

Improving adherence to treatment for atopic dermatitis (AD) is crucial for managing this chronic skin condition. Patient-centered strategies can enhance treatment outcomes and improve the quality of life for individuals with AD.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

3.4K

Related Experiment Videos

Last Updated: Mar 7, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.7K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

3.4K

Area of Science:

  • Dermatology
  • Clinical Medicine
  • Patient Adherence Research

Background:

  • Atopic dermatitis (AD) is a chronic, relapsing skin condition characterized by intense itching.
  • AD commonly affects infants and children, often persisting into adulthood.
  • Chronic nature of AD necessitates long-term treatment, posing significant management challenges.

Purpose of the Study:

  • To identify challenges in long-term atopic dermatitis treatment.
  • To explore strategies for improving patient adherence to treatment plans.
  • To enhance patient quality of life through better treatment adherence.

Main Methods:

  • Review of factors contributing to poor treatment adherence in AD patients.
  • Identification of methods to improve patient and caretaker engagement.
  • Focus on patient education and addressing fears regarding treatment.

Main Results:

  • Poor adherence in AD is linked to medication efficacy concerns, inconvenience, and fear of side effects.
  • Therapeutic plans incorporating patient preferences, early follow-ups, and education can improve adherence.
  • Addressing patient and caretaker concerns is vital for successful treatment.

Conclusions:

  • Improving adherence is key to managing chronic atopic dermatitis effectively.
  • Patient-centered approaches can significantly enhance treatment outcomes.
  • Simple adherence strategies can lead to better quality of life for AD patients.